Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Allison

Showing results (551-560 of 647) with videos related to

Pageof 65
Sort By:
Cell|September 27, 2016
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 TherapyJianjun Gao, Lewis Zhichang Shi, Hao Zhao, et al.
Immunity|March 17, 2007
T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surfaceErhu Cao, Xingxing Zang, Udupi A Ramagopal, et al.
Science Translational Medicine|June 20, 2020
<i>ARID1A</i> mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCCSangeeta Goswami, Yulong Chen, Swetha Anandhan, et al.
Journal for Immunotherapy of Cancer|May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancerMeenal Sinha, Li Zhang, Sumit Subudhi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 22, 2012
Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer modelYohei Mineharu, A K M Ghulam Muhammad, Kader Yagiz, et al.
Vaccine|April 8, 2004
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systemsPolly D Gregor, Jedd D Wolchok, Cristina R Ferrone, et al.
Cancer Immunology Research|January 8, 2017
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 BlockadeCara L Haymaker, DaeWon Kim, Marc Uemura, et al.
Physical Review Letters|March 24, 2020
Observation of Radar Echoes from High-Energy Particle CascadesS Prohira, K D de Vries, P Allison, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint BlockadeMehdi Chaib, Muhammad Aminu, Shelley Herbrich, et al.
Cancer Immunology Research|April 3, 2016
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research InstituteIra Mellman, Vanessa M Hubbard-Lucey, Matthew J Tontonoz, et al.
Pageof 65

Showing results (551-560 of 647) with videos related to

Sort By:
Pageof 65
Cell|September 27, 2016
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 TherapyJianjun Gao, Lewis Zhichang Shi, Hao Zhao, et al.
Immunity|March 17, 2007
T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surfaceErhu Cao, Xingxing Zang, Udupi A Ramagopal, et al.
Science Translational Medicine|June 20, 2020
<i>ARID1A</i> mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCCSangeeta Goswami, Yulong Chen, Swetha Anandhan, et al.
Journal for Immunotherapy of Cancer|May 14, 2021
Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancerMeenal Sinha, Li Zhang, Sumit Subudhi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 22, 2012
Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer modelYohei Mineharu, A K M Ghulam Muhammad, Kader Yagiz, et al.
Vaccine|April 8, 2004
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systemsPolly D Gregor, Jedd D Wolchok, Cristina R Ferrone, et al.
Cancer Immunology Research|January 8, 2017
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 BlockadeCara L Haymaker, DaeWon Kim, Marc Uemura, et al.
Physical Review Letters|March 24, 2020
Observation of Radar Echoes from High-Energy Particle CascadesS Prohira, K D de Vries, P Allison, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint BlockadeMehdi Chaib, Muhammad Aminu, Shelley Herbrich, et al.
Cancer Immunology Research|April 3, 2016
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research InstituteIra Mellman, Vanessa M Hubbard-Lucey, Matthew J Tontonoz, et al.
Pageof 65